Financials data is unavailable for this security.
View more
Year on year Algorae Pharmaceuticals Ltd grew revenues 197.95% from 42.02k to 125.20k while net income improved from a loss of 2.11m to a smaller loss of 2.10m.
Gross margin | -- |
---|---|
Net profit margin | -1,673.77% |
Operating margin | -1,659.46% |
Return on assets | -56.60% |
---|---|
Return on equity | -61.85% |
Return on investment | -61.85% |
More ▼
Cash flow in AUDView more
In 2024, cash reserves at Algorae Pharmaceuticals Ltd fell by 1.28m. Cash Flow from Financing totalled 523.00k or 417.73% of revenues. In addition the company used 1.52m for operations while cash used for investing totalled 277.44k.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0018 |
---|---|
Tangible book value per share | 0.0018 |
More ▼
Balance sheet in AUDView more
Current ratio | 17.89 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼